<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Johns Hopkins Nursing Research &#8211; Winter 2010</title>
	<atom:link href="http://thediabeteszone.com/2010/01/diabetes-news/johns-hopkins-nursing-research-winter-2010/feed/" rel="self" type="application/rss+xml" />
	<link>http://thediabeteszone.com/2010/01/diabetes-news/johns-hopkins-nursing-research-winter-2010/</link>
	<description>Educate Yourself and Control Your Diabetes</description>
	<lastBuildDate>Wed, 08 Feb 2012 12:41:35 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
	<item>
		<title>By: Johns Hopkins Nursing Research – Winter 2010 &#124; The Diabetes Zone &#8212; Diabetes Information</title>
		<link>http://thediabeteszone.com/2010/01/diabetes-news/johns-hopkins-nursing-research-winter-2010/comment-page-1/#comment-237</link>
		<dc:creator>Johns Hopkins Nursing Research – Winter 2010 &#124; The Diabetes Zone &#8212; Diabetes Information</dc:creator>
		<pubDate>Sat, 30 Jan 2010 01:37:28 +0000</pubDate>
		<guid isPermaLink="false">http://thediabeteszone.com/2010/01/diabetes-news/johns-hopkins-nursing-research-winter-2010/#comment-237</guid>
		<description>[...] Michael_lambert wrote an interesting post today. Here&#8217;s a quick excerptNovo Nordisk&#8217;s Victoza(R) Receives FDA Approval for Adults With bType 2 Diabetes/b PRINCETON, NJ–(Marketwire – January 26, 2010) – Novo Nordisk ( NYSE : NVO ) announced that the U.S. Food and Drug Administration (FDA) approved the new drug &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] Michael_lambert wrote an interesting post today. Here&#8217;s a quick excerptNovo Nordisk&#8217;s Victoza(R) Receives FDA Approval for Adults With bType 2 Diabetes/b PRINCETON, NJ–(Marketwire – January 26, 2010) – Novo Nordisk ( NYSE : NVO ) announced that the U.S. Food and Drug Administration (FDA) approved the new drug &#8230; [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/


Served from: thediabeteszone.com @ 2012-02-08 18:12:26 -->
